Neuland Labs Expands Capacity by 18 KL for ₹39.8 Cr

Neuland Laboratories Ltd announced board approval for a significant manufacturing capacity expansion at its Unit 1 in Telangana. The company will add 18 KL to its existing capacity, requiring an investment of ₹39.8 crores (including GST). This expansion is slated for completion within 6-7 months and will be financed through internal accruals, aimed at catering to growing customer demand. Additionally, the board approved the execution of a corporate guarantee of ₹40 crores in favor of Gland Pharma Limited for a loan license agreement to establish dedicated manufacturing capacity. The company also disclosed its unaudited financial results for the quarter ended June 30, 2026.